Slagle Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $701K | Buy |
15,149
+636
| +4% | +$29.4K | 0.28% | 70 |
|
|
2025
Q1 | $885K | Sell |
14,513
-1,813
| -11% | -$111K | 0.39% | 60 |
|
|
2024
Q4 | $923K | Sell |
16,326
-32,251
| -66% | -$1.82M | 0.42% | 60 |
|
|
2024
Q3 | $2.51M | Buy |
48,577
+3,935
| +9% | +$204K | 1.12% | 35 |
|
|
2024
Q2 | $1.85M | Buy |
44,642
+3,612
| +9% | +$150K | 0.95% | 44 |
|
|
2024
Q1 | $2.23M | Sell |
41,030
-12,894
| -24% | -$699K | 1.21% | 36 |
|
|
2023
Q4 | $1.39M | Buy |
53,924
+27,774
| +106% | +$715K | 0.8% | 54 |
|
|
2023
Q3 | $1.52M | Buy |
26,150
+2,440
| +10% | +$142K | 0.93% | 51 |
|
|
2023
Q2 | $1.52M | Buy |
+23,710
| New | +$1.52M | 0.94% | 49 |
|